Trial · NCT00556374
Adverse events2,512
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 2,512
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Double-blind Phase: Placebo | 446 | 1,690 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Double-blind Phase: Denosumab | 441 | 1,709 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Open-label Phase: Placebo/Denosumab | 0 | 245 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Open-label Phase: Denosumab/Denosumab | 0 | 1 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Double-blind Phase: Placebo | 146 | 1,690 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Double-blind Phase: Denosumab | 151 | 1,709 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Open-label Phase: Placebo/Denosumab | 0 | 245 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Open-label Phase: Denosumab/Denosumab | 0 | 1 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Double-blind Phase: Placebo | 111 | 1,690 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Double-blind Phase: Denosumab | 139 | 1,709 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Open-label Phase: Placebo/Denosumab | 0 | 245 | |
| other | Bone pain | Musculoskeletal and connective tissue disorders | Open-label Phase: Denosumab/Denosumab | 0 | 1 | |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Double-blind Phase: Placebo | 61 | 1,690 | |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Double-blind Phase: Denosumab | 89 | 1,709 | |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Open-label Phase: Placebo/Denosumab | 0 | 245 | |
| other | Osteoarthritis | Musculoskeletal and connective tissue disorders | Open-label Phase: Denosumab/Denosumab | 0 | 1 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Double-blind Phase: Placebo | 85 | 1,690 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Double-blind Phase: Denosumab | 107 | 1,709 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Open-label Phase: Placebo/Denosumab | 0 | 245 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Open-label Phase: Denosumab/Denosumab | 0 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00556374/events